Ribometrix

Ribometrix is a drug discovery company that develops small molecule therapeutics designed to target cellular RNAs and correct the production of disease-causing proteins. The company combines RNA-targeting technology with traditional drug discovery methods to create medicines that bind to or degrade disease-related messenger RNAs across various disease areas.